Aging and metabolic syndrome are associated with neurodegenerative pathologies
including Alzheimer's disease (AD) and there is growing interest in the prophylactic potential …

Brain degenerative disorders such as Alzheimer's disease (AD) can be exacerbated by
aberrant metabolism. Supplementation with probiotic bacteria is emerging as a promising …

Background Alzheimer's disease (AD), the most prevalent type of dementia, still lacks
disease-modifying treatment strategies. Recent evidence indicates that maintaining gut …

Gut microbiota has a proven role in regulating multiple neuro-chemical pathways through
the highly interconnected gut-brain axis. Oral bacteriotherapy thus has potential in the …

Introduction: Some studies have found that probiotics can improve cognitive impairment in
Alzheimer's disease, although the specific molecular mechanism by which this occurs has …

The lack of affordable and effective therapeutics against cognitive impairment has promoted
research toward alternative approaches to the treatment of neurodegeneration. In recent …

In recent years, gut microbiome alterations have been linked with complex underlying
mechanisms of neurodegenerative disorders including Alzheimer's disease (AD). The gut …

The steadily increasing prevalence of Alzheimer's disease (AD) worldwide and the lack of
effective therapeutic agent attract novel therapeutic approach in recent years. In view of the …

Alzheimer's disease (AD) is characterized by the accumulation of specific proteins in the
brain. A recent study revealed that manipulating gut microbiota (GM) significantly reduced …

Alzheimer's disease (AD) is a multifactorial pathology characterized by β-amyloid (Aβ)
deposits, Tau hyperphosphorylation, neuroinflammatory response, and cognitive deficit …